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We have measured in a defined serum-free medium the platelet-derived growth factor (PDGF) and insulin
requirements of normal Swiss 3T3 cells, simian virus 40-transformed 3T3 cells, and partial revertants of simian
virus 40-transformed 3T3 cells. Swiss 3T3 cells displayed strong requirements for both PDGF and insulin. Both
of these requirements were significantly diminished in simian virus 40-transformed 3T3 cells. Analysis of the
PDGF and insulin requirements of the revertants indicated that the loss of either of these two growth factor
requirements was not necessarily linked to the other; rather, the growth factor requirements were specifically
associated with other parameters of tranformation. The reacquisition of a PDGF requirement cosegregated
with reversion to density-dependent growth inhibition, whereas reacquisition of a normal insulin requirement
cosegregated with reversion to a normal growth dependence on calf serum. Anchorage dependence was
dissociable from both growth factor requirements. The relationship between the PDGF requirement and
density-dependent growth inhibition was further analyzed in normal 3T3 cells by measuring the PDGF
requirement at different cell densities. At high cell densities, the requirement for PDGF became significantly
greater. We suggest that at least in part the ability of transformed cells to grow to high saturation densities
results from their loss of a requirement for PDGF.
Transformation by simian virus 40 (SV40) and other
oncogenic agents often reduces the high serum growth
requirement of normal fibroblasts (11, 15, 22, 27, 30).
Several reports have led to the conclusion that a reduced
serum requirement results from the loss of a requirement for
specific growth factors. For example, Rous sarcoma virus
transformation of chicken embryo fibroblasts reduced their
requirement for the insulin-replaceable activity in serum
(30), and abortive SV40 infection of normal mouse 3T3 cells
stimulated DNA synthesis in the absence of platelet-derived
growth factor (PDGF) and the insulin-like growth factor
somatomedin C, both of which were necessary for the
stimulation of uninfected cells (24, 28). Additionally, Cher-
ington et al. discovered that a reduced epidermal growth
factor (EGF) requirement was associated with tumorigenici-
ty in a set of hamster fibroblast cell lines (5).
Not all of these reported changes need be directly related
to a reduced serum dependence. Transformed cells often
exhibit other alterations in growth control, such as the loss
of density-dependent growth inhibition and the loss of a
normal anchorage requirement (22). If the loss of a specific
growth factor requirement is directly linked to a reduced
serum requirement, then the two phenotypes should cose-
gregate upon reversion. Revertants of SV40-transformed
cells that have regained a normal serum dependence have
been isolated (33, 34). Since wild-type SV40 can be rescued
from these revertants and since they continue to express
SV40 T-antigen, it is thought that these revertants harbor a
cellular mutation that reverses the phenotype of a reduced
serum dependence or, alternatively, that due to the in-
creased chromosomal content of these revertants extra
copies of some normal cellular gene can suppress the trans-
formed phenotype (33, 34). For some of these revertants, the
presumptive cellular alteration affects the serum require-
* Corresponding author.
ment without affecting the ability to grow without anchorage
to a solid substrate (34).
Previously, evidence was provided that intracellular cyclic
AMP concentrations in mouse fibroblasts responded specifi-
cally to growth regulation by serum and not to density-
dependent growth regulation (19). Serum-sensitive rever-
tants regained the property of responding to serum
deprivation by a sharp rise in intracellular cyclic AMP
levels. In contrast to this linkage of cyclic AMP response to
serum dependence, serum-sensitive revertants did not regain
the normal response to serum deprivation or to a reduction
in the transport rates of either glucose or amino acids (9).
This finding is in agreement with other reports that cell
growth is dissociable from increased nutrient uptake (32, 37).
In this paper, we report that the reversion to calf serum (CS)
dependence for mouse fibroblasts is linked to the reacquisi-
tion of an insulin requirement but is dissociable from the
requirement for PDGF. The requirement for PDGF, in
contrast, appears to be tightly associated with density-
dependent growth inhibition.
MATERIALS AND METHODS
Cell lines. Swiss 3T3 cells, SV40-transformed Swiss 3T3
cells (clone SV101), and the revertants derived from SV101
were maintained in 10% fetal calf serum-Dulbecco modified
Eagle medium (FCS/DME; vol/vol) with 100 U of penicillin
per ml and 100 ,ug of streptomycin per ml. SV101 was cloned
from SV40-infected Swiss 3T3 cells (21). Revertant
FLSV101 (FLSV) was derived from SV101 by 5-
fluorodeoxyuridine-negative selection at high density (21).
Serum revertants AvSV101-4 (Av4) and LSSV101-1 (LS1)
were derived from clone SV101 by bromodeoxyuridine-
negative selection at low density in a gamma globulin-
depleted serum and in low (1%) serum, respectively (34).
Kirsten murine sarcoma virus (Ki-MuSV)-transformed Av4
cells (Ki-Av4) were isolated from a morphologically altered,
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(35). NIH-3T3 cells were obtained from M. Wigler, and
NIH-DT cells, a Ki-MuSV-transformed derivative of NIH-
3T3 cells isolated in the laboratory of E. Scolnick, were
obtained from V. Vogt. All cell lines were found to be free of
mycoplasma contamination by the fluorescence method of
Chen (4).
The published properties of these cell lines (anchorage
requirement, serum requirement, and saturation density)
were confirmed recently in this laboratory. However, the
use of FCS in place of CS proved unsatisfactory for the
measurement of the serum requirement. All cell lines grew
significantly faster in 1% FCS than they did in 1% CS. The
ratios of doubling times in 1% CS to 10% CS were as
reported, except that previously Ki-Av4, like Av4, did not
grow at all in 1% CS (35), and in recent experiments, Ki-Av4
retained a normal serum requirement, but like 3T3, grew
slowly in 1% CS. Saturation densities in 10% FCS were
within a 0.4-fold range of previously published values (35).
Plating efficiency (PE) in Methocel (Dow Chemical Co.) with
10% FCS yielded values that were within a twofold range of
published values, except that clone SV101 had a 7% PE
instead of a 20% PE, Ki-Av4 had a 6% PE instead of a 20%
PE, and serum revertant LS1 had a 0.01% PE instead of a
0.001% PE (35).
Growth factors and basal medium. Insulin. EGF, and
fibroblast growth factor (FGF) were purchased from Collab-
orative Research, Inc. Human transferrin was purchased
from Sigma Chemical Co. Fibronectin was purified from
human plasma by gelatin-affinity chromotography essential-
ly as described previously (12), with the modification that
bound fibronectin was eluted with 1 M NaBr-10 mM sodium
phosphate (pH 5.5). Fibronectin was dialyzed against phos-
phate-buffered saline and diluted to 0.1,ug/ml or less before
filter sterilization. Filtration resulted in a considerable loss
of protein; hence, the fibronectin concentration was deter-
mined after filtration. Partially purified PDGF was prepared
from 100 U of outdated human platelets (New York Blood
Center) by the method of Heldin et al. (14). Platelet lysate
was purified sequentially by carboxymethyl cellulose-Sepha-
dex chromotography, Blue-Sepharose chromotography, and
molecular sizing on a Bio-Gel P150 column. The final steps
were carried out aseptically to avoid filter sterilization. The
assay for PDGF mitogenic activity consisted of measuring
the additional growth of 3T3 cells in totally defined serum-
free medium in the presence of insulin, EGF, and transferrin
as described below. Of the partially purified PDGF, 60 ng/ml
displayed mitogenic activity, corresponding to 20 ng of
purified PDGF per ml (kindly provided by C. H. Heldin).
MCDB 402 medium was prepared as described previously
(26) from double glass-distilled water (2) with the following
modifications for use with 10% CO, incubators: 4.6 g of
NaCI per liter, 3.0 g of NaHCO3 per liter, and 10 mM
HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic
acid). The final concentrations of three components were
changed to the following: biotin, 100 ng/ml; vitamin B12, 3 x10-7 M: and sodium silicate, 10-6 M. We also added either
100,ug of streptomycin per ml and 100 U of penicillin per ml
or 50,ug of gentamicin per ml. We found it beneficial to make
fresh stock solutions for MCDB 402 medium every 6
months. All glassware, including pipettes, were acid washed
before use.
Serum-free cell culture. Our protocol utilized culture dish-
es that were sequentially coated with sterile 0.1%poly-D-
lysine (Sigma Chemical Co.) for 10 min, washed once with
phosphate-buffered saline, and treated with 1,ug of fibronec-
tin percm2 in DME for 30 min at 37°C, followed by one wash
with serum-free DME. Cells were harvested and plated in
MCDB 402 medium as follows: subconfluent dishes of cells
grown in 10% serum were washed once with 0.5 mM EDTA
(ethylenediaminetetraacetic acid-phosphate-buffered saline
and allowed to detach in a small volume of phosphate-
buffered saline. The detached cells were diluted into MCDB
402 medium, centrifuged, resuspended in MCDB 402 medi-
um, and counted with the aid of a Coulter Counter. The cells
were plated with sterile polypropylene pipette tips. Plates
were fed twice weekly. The growth factors used were
insulin, 10 ,ug/ml: transferrin, 5 p.g/ml; EGF, 40 ng/ml; and
partially purified PDGF, 60 ng/ml. Experiments with FGF
utilized 10 ng/ml in place of PDGF.
To determine the relative growth rates, cells were plated
on 35- or 60-mm Nunc dishes as described in the text.
Replicate plates for each condition were counted on the
indicated days. The average number of doublings in the
restrictive condition was divided by the average number of
doublings in the nonrestrictive condition to determine the
relative growth rate. In some cases, the growth factor whose
mitogenic response was being measured was not added until
day 1.
The standard errors of relative measurements were deter-
mined by the relationship Srm2/Xrm2 = + Snr /Xnr2 (1),
where Xrm, Xr, and Xnr are the average values of the relative
measurement, growth in the restrictive condition, and
growth in the nonrestrictive condition, respectively, and
Srm, Sr, and Snr are the corresponding standard errors.
Analysis of variance was used to determine the significance
of the difference in relative measurements between two cell
lines.
RESULTS
Growth of Swiss 3T3 cells in defined medium. We have
modified the serum-free formula for Swiss 3T3 cells devel-
oped by Serrero and co-workers (25). The protocol we
employed involves the treatment of culture dishes with poly-
D-lysine and fibronectin, the replacement of DME with an
enriched modification of DME termed MCDB 402 medium
(26), and the addition of the following growth factors: PDGF,
insulin, EGF, and transferrin. When Swiss 3T3 cells were
plated in this serum-free medium, the growth rate was
comparable to that obtained with 10% serum (doubling time,
22 h). The requirement for PDGF and insulin will be dis-
cussed in detail below. However, EGF and transferrin could
be deleted from the medium without any significant change
in growth rate (data not shown). It is likely that the addition
of freshly dissolved ferrous sulfate to the basal medium
obviates the requirement for tranferrin, as has been shown in
several other systems (26). The lack of requirement for EGF
was somewhat surprising in view of the work of Wharton et
al. (38), who showed that EGF, in addition to PDGF and
insulin, was required for reentry into the cell cycle of
confluent 3T3 cells. One possible explanation for our results
is that our cells were not in stationary phase when placed
into the serum-free medium and that EGF is only required
during the transition from stationary phase to active prolif-
eration.
Reduced PDGF requirement in SV40-transformed 3T3
cells. Swiss 3T3 cells displayed a strong requirement for
PDGF. In its absence, the growth rate was about one half
that with PDGF (Table 1). In sharp contrast,SV40-trans-
formed 3T3 cells (clone SV101) did not require PDGF at all
(Table 1). This finding is in agreement with earlier work with
platelet-poor plasma that indicated thatSV40-transformed
3T3 cells did not require PDGF (24). Eight other independent
SV40-transformed 3T3 cell lines also displayed a significant-
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TABLE 1. PDGF requirement of mouse fibroblasts"
Growth control phenotypes Relative growth
Cell line rate (-PDGFI
Serum Density Anchorage +PDGF)
Swiss 3T3 N N N 0.52 ± 0.03
SV101 T T T 1.04 0.06
FLSV T N N 0.22 0.05
LS1 N N N 0.62 ± 0.03
Av4 N N T 0.48 ± 0.07
Ki-Av4 N T T 1.01 ± 0.05
a The PDGF requirement was determined by plating 2 x 104 cells per 35-
mm dish on poly-D-lysine-fibronectin-coated dishes containing 2 ml of MCDB
402 medium plus (per ml): 10 pLg of insulin, 5 ,ug of transferrin, and 40 ng of
EGF. Twenty-four hours later, duplicate plates were counted, and 60 ng of
partially purified PDGF per ml was added to half of the remaining dishes. Cell
counts were determined 4 days later. N, Normal; T, transformed.
We examined the PDGF requirements of three partial
revertants of clone SV101. All three of these revertants were
previously found to express T-antigens (both 96,000 and
17,000 molecular weight) and to yield wild-type SV40 upon
fusion with monkey cells (3, 35). They have regained some
but not necessarily all growth properties of Swiss 3T3 cells
(Table 1). All three revertants had reacquired a stronger
PDGF requirement (Table 1). It is of interest that FLSV, a
flat revertant selected for survival at high densities in the
presence of the killing agent 5-fluorodeoxyuridine, had reac-
quired a strong PDGF requirement but retained the low
serum requirement of clone SV101 (Table 1). Thus, it does
not appear that the requirement for high serum concentra-
tions, as measured by comparison of growth rates in 10
versus 1% CS, correlates with the requirement for PDGF.
Besides PDGF dependence, the phenotype that is shared by
all three of the revertants, but not by clone SV101, is
density-dependent growth inhibition (Table 1). Retransfor-
mation of the revertant Av4 with Ki-MuSV reduced both
PDGF dependence and density-dependent growth inhibition
(Table 1). This tentative relationship between density-depen-
dent growth inhibition and a requirement for PDGF may be
fortuitous, but the following additional lines of evidence
suggest that it is substantial: (i) Vogel et al. (36) found that
PDGF, and not plasma, which contains insulin-like growth
factors, was the major determinant of the final saturation
density achieved by 3T3 cells; (ii) there was a significant
correlation between the degree of PDGF independence and
the ability to grow to high saturation densities in the eight
independent SV40 transformants (data not shown); and (iii)
we have found that the requirement for PDGF by 3T3 cells is
more stringent at higher cell densities (Table 2).
PDGF affects the insulin requirement of 3T3 cells. The final
step in our development of the serum-free medium for 3T3
cells was the replacement of PDGF for FGF. PDGF and FGF
are interchangeable in many short-term assays (24, 28).
However, 10 ng of PDGF per ml was more potent than 10 ng
TABLE 2. Effect of cell density on PDGF requirement
Inoculum cell Doublings Relative
densitya +PDGF -PDGF growth
1 x 105 3.4 0.4 0.11
3 x 104 3.6 1.4 0.39
1 X 104 3.3 1.7 0.52
3 x 103 2.0 1.1 0.55
a Cells per 60-mm dish. Growth was monitored in a 4-day assay as
described in Table 1, footnote a.
of FGF per ml for the growth of Swiss 3T3 cells in a 3-day
growth assay (Table 3). However, PDGF severely depresses
the strong requirement for insulin that we previously ob-
served with FGF in the medium (Table 3). PDGF is known to
be a potent stimulator of the secretion of somatomedin C
(insulin-like growth factor I [IGF-I]) by fibroblasts (6). Thus,
a more sensitive assay of the insulin requirement necessitat-
ed the use of FGF instead of PDGF.
Insulin requirement of SV40-transformed 3T3 cells and
revertants. Previously, other investigators have reported
that SV40-transformed cells require insulin for growth in
serum-free medium (23). However, no comparison was
drawn with normal cells. The strong insulin requirement of
normal 3T3 cells is severely diminished in clone SV101
(Table 4). Since clone SV101 mitogenically responds to
insulin, we agree that SV40-transformed 3T3 cells require
insulin for optimal growth. However, when the response or
requirement is compared with that of normal 3T3 cells, it is
apparent that clone SV101 does not slow down its growth in
response to insulin deprivation to nearly the same extent as
do normal 3T3 cells (Table 4). This differential effect is
also observed when PDGF is employed; however, the differ-
ence is not as dramatic (Table 4). Other SV40-transformed
3T3 cells also displayed a significant reduction in their
requirement for insulin (data not shown).
The serum-sensitive revertant LS1 regained a stronger
insulin requirement, paralleling its reacquisition of a normal
serum requirement (Table 4). The serum-sensitive revertant
Av4 also grew very inefficiently without insulin. Thus, both
serum-sensitive revertants of clone SV101 #were found to
have regained a 3T3-like insulin requirement.
FLSV, a flat anchorage-dependent revertant of clone
SV101 that retained a low serum requirement (Table 1),
displayed a minimal requirement for insulin, similar to that
of clone SV101 (Table 4). This shows that the loss of the
insulin requirement cosegregates with the loss of serum
dependence and not with the loss of the anchorage require-
ment or the loss of density-dependent growth inhibition.
Retransformation of revertant Av4 with Ki-MuSV affected
neither its serum dependence nor its insulin requirement
(Table 4).
DISCUSSION
Our results indicate that SV40 transformation can drasti-
cally alter the growth factor requirements of normal fibro-
blasts. Both the PDGF and insulin requirements found in
normal 3T3 cells were diminished or abolished after SV40
transformation. It will be important to determine whether
either or both of these diminished growth factor requirements
are necessary for tumor formation. Neoplastic transforma-
tion can alter many cellular properties, but only some of
them have been shown to be directly related to tumorigeni-
city. For example, the loss of cell surface fibronectin is not




Insulin, EGF, FGF 1.5
EGF, FGF 0.5 033
Insulin, EGF, PDGF 2.6
EGF,PDGF 1.9 073
a 3T3 cells were plated onto poly-D-lysine-fibronectin-coated 60-mm dishes
containing 4 ml ofMCDB 402 medium supplemented with or without (per ml):
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TABLE 4. Insulin requirement of mouse fibroblasts"
Inclusion of: Relative growth
Cell line rate (-Ins/
PDGF FGF + Ins)
Swiss 3T3 - + 0.30 ± 0.06
SV101 - + 0.73 ± 0.05
FLSV - + 0.79 ± 0.07
LS1 - + 0.53 ± 0.02
Av4 - + 0.10 ± 0.04
Ki-Av4 - + 0.19 ± 0.05
Swiss 3T3 + - 0.71 ± 0.03
SVo10 + - 0.85 ± 0.02
a Cells were plated at a density of 2 x 104 per 35-mm dish. The medium was
supplemented with either 10 ng FGF per ml or 60 ng of partially purified
PDGF per ml as indicated, plus 40 ng of EGF per ml and 5 ,ug of transferrin per
ml. Some plates received insulin (Ins). Duplicate plates for each condition
were counted on days 1 and 5. The numbers were converted to doublings. and
the values represent the relative growth rates ± standard errors.
necessary for tumor formation (16). However, it has been
well established that anchorage independence is a necessary
prerequisite for tumor formation of both fibroblastic and
epithelial cells (16). Recently, Perez-Rodriguez (20) reported
that a reduced serum requirement, in addition to anchorage
independence, was a necessary prerequisite for tumorigeni-
city in hamster fibroblasts.
Many transformed cells and human tumor cell lines would
appear to be able to escape the requirement for specific
growth factors by virtue of their secretion of growth factors
homologous to either EGF or the insulin-like growth factor
multiplication-stimulating activity (MSA) (8, 13). Murine
sarcoma virus- and adenovirus-transformed rodent cells
secrete an EGF-like growth factor that induces certain
normal rat cell lines to grow in soft agar and also prevents
the binding of exogenous, labeled EGF (8, 13). Secretion of
homologous growth factors by SV40-transformed cells may
underlie their ability to grow well in the absence of PDGF or
insulin. SV40 T-antigen could conceivably stimulate the
synthesis of PDGF or insulin-like growth factors at the level
of RNA transcription. It is of interest that clone SV101 has
been found to have a reduced level of PDGF receptors and
also appears to secrete a PDGF-like peptide into culture
medium (A. Vogel, personal communication). We are cur-
rently measuring PDGF receptors in the set of revertants
examined in this report.
Two significant findings emerged from the selective reac-
quisition of growth factor requirements by revertants: (i) the
loss of the PDGF requirement was directly associated with
the loss of density-dependent growth inhibition, and (ii) the
loss of the strong insulin requirement was directly associated
with a reduced serum dependence. In light of the first
finding, it has been known for some time that the final
saturation density of normal fibroblasts is directly propor-
tional to the serum concentration (15). Recently, Vogel et al.
have provided evidence that PDGF is the serum component
responsible for this determination of final saturation density
(36). Our results are in concert with this finding and suggest
that the loss of the PDGF requirement enables cells to grow
to high saturation densities. Selective reacquisition of only
the PDGF requirement appears to be a sufficient alteration to
restore density-dependent growth inhibition to the flat rever-
tant FLSV.
McClure (18) found that SV40-transformed 3T3 cells dis-
played a requirement for PDGF only when suspended in agar
or when deprived of fibronectin-coated substrate. This
seems to suggest that cell shape is involved in the require-
ment for PDGF. We have shown that 3T3 cells display a
much stronger requirement for PDGF when plated at high
cell densitids,fwNih may result from changes in cell shape as
cells approach confluence.
Our finding.t1'at the loss of a stringent insulin requirement
is directly r6iated to a reduced serum dependence is in
agreement with the work of Temin, who found that Rous
sarcoma virus-transformed chicken fibroblasts had a re-
duced serum dependence (30) and that this reduced serum
dependence resulted from a diminished requirement for the
insulin-replaceable activity in serum (31). Partial purification
of the major mitogenic activity in CS for the growth of
chicken fibroblasts revealed that this activity was closely
related to the insulin-like growth factor MSA (10). Other
laboratories have reported a reduced insulin requirement
after neoplastic transformation. Moloney sarcoma virus-
transformed dog kidney epithelial cells have been reported
to have a reduced requirement for insulin when compared
with their normal counterparts (29). The insuliti growth
requirement for fibroblasts is likely to represent a require-
ment for somatomedin or insulin-like growth factors (7, 17).
The somatomedin IGF-I totally substitutes for insulin in our
growth assay (S. Powers, unpublished data). Somatomedins
are thought to mediate many if not all of the growth-
promoting effects of growth hormone (17). It would not be
surprising if escape from this major humoral growth regula-
tory system by a single cell influenced its growth potential in
vivo.
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